SEC Filings for Actinium Pharmaceuticals Inc. (Delaware) (ATNM)

$ 0.2023   0.0017 (+0.85%) Volume: 770.15k 1:23 PM EDT 31-Mar-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
S-3/A[Amend] Registration statement under Securities Act of 1933910/03/2017
4Statement of changes in beneficial ownership of securities108/04/2017
10-QGeneral form for quarterly reports under Section 13 or 15(d)14008/04/2017
4Statement of changes in beneficial ownership of securities108/04/2017
SC 13GStatement of acquisition of beneficial ownership by individuals108/04/2017
424B5Prospectus [Rule 424(b)(5)]24007/31/2017
8-KCurrent report pursuant to Section 13 or 15(d)6207/28/2017
424B5Prospectus [Rule 424(b)(5)]24007/27/2017
424B5Prospectus [Rule 424(b)(5)]5307/03/2017
8-KCurrent report pursuant to Section 13 or 15(d)207/03/2017
3Initial statement of beneficial ownership of securities106/19/2017
8-KCurrent report pursuant to Section 13 or 15(d)306/16/2017
123456789101112131415